Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Seattle Biotech -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (29)	7/19/2001 11:53:30 AM
From: keokalani'nui	Read Replies (1) \| Respond to of 70

ZymoGenetics Names George B. Rathmann as Chairman of the Board SEATTLE, July 19 /PRNewswire/ -- In a move that further strengthens the leadership of ZymoGenetics, Inc., George B. Rathmann, Ph.D. has been named Chairman of the company's Board of Directors. Dr. Rathmann, a biotechnology pioneer and current ZymoGenetics Board member, is also Chairman of Hyseq, Inc. _______________ Spiffing it up nicely, but as a potential investor I don't care to pay what is usually charged at the IPO for a prominent Board Chairman. It's not as though Zymo is a start-up. Wilder